SHELL ASSET MANAGEMENT CO - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 177 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2020. The put-call ratio across all filers is 0.12 and the average weighting 0.7%.

Quarter-by-quarter ownership
SHELL ASSET MANAGEMENT CO ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$281,000
-17.8%
1,862
-20.7%
0.01%
+10.0%
Q2 2022$342,000
+23.0%
2,348
+0.2%
0.01%
+42.9%
Q1 2022$278,000
-25.1%
2,344
-12.9%
0.01%
-12.5%
Q4 2021$371,0000.0%2,690
+0.7%
0.01%0.0%
Q3 2021$371,000
+37.4%
2,671
-4.0%
0.01%
+60.0%
Q2 2021$270,000
+50.0%
2,781
+5.7%
0.01%
+25.0%
Q1 2021$180,000
-54.5%
2,631
-43.1%
0.00%
-50.0%
Q4 2020$396,000
+31.6%
4,6230.0%0.01%
+14.3%
Q3 2020$301,000
-10.9%
4,6230.0%0.01%
-12.5%
Q2 2020$338,000
+111.2%
4,623
-1.8%
0.01%
+100.0%
Q1 2020$160,000
-38.5%
4,706
-1.5%
0.00%
-33.3%
Q4 2019$260,000
+26.8%
4,777
-2.7%
0.01%
+20.0%
Q3 2019$205,000
-5.5%
4,911
-0.8%
0.01%0.0%
Q2 2019$217,000
-16.9%
4,953
-2.2%
0.01%
-16.7%
Q1 2019$261,000
+39.6%
5,0650.0%0.01%
+20.0%
Q4 2018$187,000
-8.8%
5,065
-7.3%
0.01%
+25.0%
Q3 2018$205,0005,4650.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q1 2020
NameSharesValueWeighting ↓
RP Management, LLC 2,111,111$108,659,00054.35%
Knoll Capital Management, LLC 749,815$38,593,00029.33%
VHCP Management II, LLC 1,138,075$58,577,00017.14%
ORACLE INVESTMENT MANAGEMENT INC 1,021,392$52,571,00011.19%
Aisling Capital Management LP 274,513$14,129,00010.76%
Foresite Capital Management IV, LLC 518,560$26,690,0009.59%
KINGDON CAPITAL MANAGEMENT, L.L.C. 844,266$43,454,0005.81%
ACUTA CAPITAL PARTNERS, LLC 206,000$10,603,0005.04%
ARS Investment Partners, LLC 464,127$23,889,0004.32%
Cormorant Asset Management, LP 1,100,000$56,617,0003.83%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders